A Study to Assess and Compare the Effects of 5 mg vs. 20 mg Desloratadine on the Development of Cold Urticaria Lesions
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare cold urticaria lesions by thermography, volumetry and
digital time lapse photography in ACU patients treated with placebo, 5 mg and 20 mg
desloratadine. Hypothesis: The updosing of desloratadine (20 mg)is more effective in the
treatment of ACU symptoms as compared to standard doses (5 mg desloratadine) and placebo.